No abstract

Background: The COVID-19 pandemic has posed an unprecedented threat to global healthcare delivery. Moewardi Hospital was appointed by the government of Indonesia to be a COVID-19 one of regional hospital by June 2020. Other than COVID-19 cases, the hospital also provides care for other diseases which also provides care for oncology patients. The aim of the study: to assess the impact of the social restriction on oncology services in this hospital. Materials and Methods: This study compares the number of patients undergoing oncology surgery in the Central Surgery Unit and the number of patients attending the Outpatient Surgical Oncology Unit in March to July 2020 with the number of patients in the same timeframe in the previous year (2019). Results: The number of oncology operations in the Central Surgery Unit of Moewardi Hospital declined substantially during the 5-month pandemic period compared to the same period in the previous year, 2019 (p<0.001). There was also a significant drop in the number of patients attending the outpatient surgical oncology clinic during the pandemic period compared to the previous year (p<0.001) The lowest number of oncology surgeries occurred in April 2020, which was 20 patients. The lowest number of patients visited was 170 outpatients in March 2020. Thyroid and skin cancer cases were the most notable decline in surgical oncology cases in the Central Surgery Unit. The largest number of outpatients in the outpatient surgical oncology clinic during the COVID-19 pandemic was mammae and thyroid cancer. Conclusions: There was a decline in surgical oncology activities, which culminated in a significant decrease in surgical oncology patients in the Central Surgery Unit and the patient visit to the Moewardi Hospital outpatient oncology clinic during the COVID-19 pandemic.

Thyroid cancer is a thyroid gland malignancy with an increasing incidence, especially in women aged 25-65 years. The tumor, node, and metastases classification serves to determine cancer management. Here, we report the case of 58 years old who came with complaints of lumps in the neck and the left armpit for 2 months. Based on the results of the systemic history, physical examination, and supporting examinations including X-rays, ultrasound, magnetic resonance imaging, and biopsy, a final diagnosis of T4bN1bM1 thyroid papillary cancer (lung) with a left axillary mass, which is cancer thyroid metastases, was given. The management carried out in these patients was chemotherapy with chemotherapy regimens doxorubicin (20 mg/m 2 ) iv and paclitaxel (60 mg/m 2 ) iv once per week, respectively, but unfortunately, the patient died due to respiratory failure. This case report tries to elaborate the chemotherapy effects on neglected thyroid carcinoma metastatic to the axilla so that the clinicians have representation about these effects.

Background: The novel coronavirus known as SARS-CoV-2 has spread worldwide and caused the COVID-19 pandemic. In September 2020, more than 32 million confirmed cases of COVID-19, with a death toll of more than 990,000. Among COVID-19 patients, those with cancer had worse outcomes than those without malignancy, but in some studies, the mortality rates differed significantly, ranging from 3.7% to 61.5%. Method: In this descriptive study, survival analysis with the Kaplan Meier curve was used to determine the healing rate of patients with cancer exposed to COVID-19 and undergoing treatment at dr. Moewardi General Hospital Surakarta-Indonesia from February to December 2020, and the Log Rank test was used to analyze data on two related groups. Results: The analysis using the Kaplan Meier method, female patients were found to have a higher survival rate than females, paged less than 50 years had a higher survival rate than those aged > 51 years, breast cancer had the lowest survival rate, and comorbidity of anemia had a higher survival rate than those with other comorbidities. The Log Rank test found a significant difference in the cumulative survival rates of cancer patients with COVID-19 with a p-value of 0.010 for comorbidity types. Meanwhile, from gender (p = 0.632), age (p = 0.672), type of cancer (p = 0.472), there was no significant difference. Conclusion: COVID-19 female patients aged less than 50 years with types of malignancy other than breast cancer and comorbidity of anemia have a higher survival rate..